Scleroderma & COVID-19: A Conversation with the Experts
Do you have questions surrounding COVID-19 in scleroderma? SPIN, The Scleroderma Patient-centered Intervention Network, is here to help.
SPIN in sponsorship with the Scleroderma Society of Ontario, Scleroderma Canada, and the Scleroderma Foundation, presents “Videoforum – Scleroderma & COVID-19: A Conversation with the Experts”.
This Saturday, March 11th, at 11:00 am EDT (timezone equivalents are given in the attached documents)
An English videoforum with 5 excellent panelists! Tune in to ask your questions live by typing them into the Chat Pane or submit your questions in advance here: https://survey.co1.qualtrics.com/jfe/form/SV_ekUhpM68wg2AmTX
Online (a max capacity of 250 attendees) anyone can join using this link: www.gotomeet.me/SPIN-SSLED (Access code: 575-114-197)
HOW TO JOIN?
A step-by-step guide to launching can be found here: https://www.dropbox.com/s/enoltdjd05023b7/GoToMeeting-%20Instructions-%20videoforum_final.pdf?dl=0
news & events
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.
We are happy to share with you our latest newsletter. Read about World Scleroderma Day 2021, projects, our next world congress and more.